Country:China>Guangdong>Zhuhai
No.5002 South Nanwan Road,Xiangzhou District
Company:Zhuhai Wumei Technology
Mobile:+86 17707567455
Tell0756-8811069
Fulvestrant CAS: *-61-8 MF: C32H47F5O3S MW: 606.77 EINECS: Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Nuclear Receptors;Chiral Reagents;Steroids;Sulfur & Selenium Compounds;FASLODEX;Anti-cancer&immunity;Inhibitors. Melting point 104-106°C storage temp. 2-8°C Indications and Usage Fulvestrant is a muscle injection drug developed by the company AstraZeneca and is suitable for treating postmenopausal women with estrogen receptor-positive metastasized breast cancer whose condition continued to worsen despite antiestrogen treatment. Fulvestrant is the only antiestrogen drug that can be widely clinically used following unsuccessful tamoxifen treatment. This drug is a type of endocrine therapy, so it will not cause any adverse effects commonly seen in chemotherapy, giving it relatively good patient compliance. Multiple clinical trials have found that 250mg Fulvestrant is effective and consistently safe as a second line of treatment for advanced breast cancer.
Avoid fraud by meeting all sellers in-person to pay for items. BestB2B.COM does not offer any transaction or payment services.